Working… Menu
Trial record 1 of 1 for:    NCT03828201
Previous Study | Return to List | Next Study

Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB (DRAMATIC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03828201
Recruitment Status : Not yet recruiting
First Posted : February 4, 2019
Last Update Posted : November 17, 2020
Novartis Pharmaceuticals
Otsuka Pharmaceutical Co., Ltd.
University of California, San Francisco
National Institute of Allergy and Infectious Diseases (NIAID)
University of Colorado, Denver
Harvard Medical School
National Lung Hospital, Vietnam
De La Salle Health Sciences Institute, Philippines
Information provided by (Responsible Party):
Boston University

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : July 2025
Estimated Study Completion Date : July 2025